Search Results 721-730 of 16342 for monoclonal antibody

  1. Metastatic Colorectal Cancer Clinical Trials - Mayo Clinic Research

    Monoclonal antibodies, such as cetuximab, may block the ability of tumor cells to grow and spread. It is not yet known whether irinotecan hydrochloride and ...

  2. Immunogenetics of COVID-19 Immune Response - Mayo Clinic

    The purpose of this study is to measure SARS-CoV-2 Spike protein antibody titers in a vaccinated cohort. ... Receipt of any COVID-19-specific monoclonal ...

  3. Plasma Exchange and Glucocorticoids for Treatment of Anti-Neutrophil Cytoplasm Antibody (ANCA) - Associated Vasculitis - Mayo Clinic

    Plasma Exchange and Glucocorticoids for Treatment of Anti-Neutrophil Cytoplasm Antibody (ANCA) - Associated Vasculitis. Print details. Share; Facebook · Twitter.

  4. A Study Evaluating the Efficacy and Safety of Cevostamab in Prior B Cell Maturation Antigen (BCMA)-Exposed Participants With Relapsed/Refractory Multiple Myeloma (CAMMA 2) - Mayo Clinic

    antibody (TDB) antibody including non BCMA targeting TDB - Prior use of any monoclonal antibody (mAb), radioimmunoconjugate, or ADC as anti-cancer therapy ...

  5. Breast Cancer Surgery Clinical Trials - Mayo Clinic Research

    Monoclonal antibodies, such as trastuzumab, can block tumor growth in different ways. Some block the ability of tumor cells to grow and spread. Others find ...

  6. A Study to Refine and Modify the Granulocyte Antibody Test to Provide Patients the Most Sensitive and Accurate Blood Serum Assay Available. - Mayo Clinic

    A Study to Refine and Modify the Granulocyte Antibody Test to Provide Patients the Most Sensitive and Accurate Blood Serum Assay Available. · Share · Facebook ...

  7. Study of Imprime PGG and Pembrolizumab in Advanced Melanoma and Triple Negative Breast Cancer - Mayo Clinic

    Had a prior anti-cancer monoclonal antibody (except immune CPI in the case of melanoma subjects) within 30 days prior to start of study treatment, or ...

  8. Gary A. Croghan, M.D., Ph.D. - Doctors and Medical Staff - Mayo Clinic

    ... Monoclonal Antibody F36/22State University of New York at Buffalo. 1983. Research Affiliate - Diagnostic Immunology Research & BiochemistryRoswell Park Cancer ...

  9. A Study of JNJ-68284528, a Therapy Directed Against B-Cell Maturation Antigen (BCMA) in Participants with Relapsed or Refractory Multiple Myeloma - Mayo Clinic

    Monoclonal antibody treatment for multiple myeloma within 21 days;; Cytotoxic therapy within 14 days;; Proteasome inhibitor therapy within 14 days ...

  10. Estradiol in Treating Patients With ER Beta Positive, Triple Negative Locally Advanced or Metastatic Breast Cancer - Mayo Clinic

    Monoclonal antibodies;; Anti-HER2 or other "targeted" (e.g., mTOR) therapy. *Note: Any adverse events derived from these therapies must be ≤ Grade 2 prior ...